Basal cell carcinoma (BCC) is the most common form of skin cancer, accounting for roughly 75 to 80 percent of all skin cancer diagnoses worldwide. It’s also the most common cancer of any kind. The second most common skin cancer, squamous cell carcinoma, occurs at roughly half the rate. Melanoma, the type most people fear, is far less frequent than either.
How Common BCC Actually Is
Population data from Olmsted County, Minnesota gives a useful snapshot of how these cancers compare. Over a decade of tracking, basal cell carcinoma occurred at a rate of about 360 per 100,000 men and 293 per 100,000 women each year. Squamous cell carcinoma came in at 208 per 100,000 men and 129 per 100,000 women. That means BCC is roughly 1.5 to 2 times more common than squamous cell carcinoma, depending on sex.
These numbers have been climbing for decades, driven by cumulative sun exposure in aging populations and the lingering effects of tanning culture from previous generations.
What BCC Looks Like on Different Skin Tones
Basal cell carcinoma doesn’t always look the way people expect. On lighter skin, it typically appears as a shiny, skin-colored or pink bump that looks slightly translucent, almost pearly. Tiny blood vessels may be visible on its surface, and it can bleed and scab over repeatedly without fully healing.
On brown and Black skin, the same cancer often looks brown or glossy black with a rolled border. This difference in appearance can lead to delayed diagnosis in people with darker skin tones, since many of the classic descriptions in medical literature focus on how BCC looks on white skin.
BCC can also show up as a flat, scaly patch that slowly expands over months or years, or as a white, waxy, scar-like area with no clear border. A less common variant appears as a brown, black, or blue spot with a slightly raised, translucent edge. Any sore that keeps returning, or a spot that bleeds, crusts, and never quite heals, is worth having examined.
The Three Main Subtypes
Not all basal cell carcinomas behave the same way. There are three main clinical subtypes, and the distinction matters because it affects how aggressive the cancer is and how it gets treated.
- Nodular BCC is the most common type on the face. It appears as a shiny, pearly bump with a smooth surface that may develop a central depression or ulcer, giving the edges a rolled appearance. Blood vessels often cross its surface.
- Superficial BCC is the most common type in younger adults and tends to appear on the upper trunk and shoulders rather than the face. It looks like a slightly scaly, irregular patch with a thin, translucent border.
- Morphoeic BCC is the most concerning subtype. It shows up as a waxy, scar-like patch with indistinct borders, usually on the mid-face. It extends wider and deeper beneath the skin than it appears on the surface and can spread along nerves.
Why UV Exposure Is the Primary Cause
Ultraviolet radiation from the sun, particularly UVB rays, is the single most significant environmental risk factor for basal cell carcinoma. The cancer develops from cells in the deepest layer of the outer skin (the epidermis), where UV damage accumulates over time and triggers uncontrolled cell growth.
Both patterns of sun exposure contribute to risk: the steady, day-after-day exposure that outdoor workers get, and the intense, intermittent burns that weekend beachgoers experience. Some research suggests that intense intermittent exposure may carry a higher risk than steady cumulative exposure, but the evidence isn’t settled. What is clear is that both patterns are harmful, and childhood sun exposure matters as much as adult exposure.
Other risk factors include fair skin, a history of sunburns, use of tanning beds, radiation therapy to the skin, a weakened immune system, and certain genetic conditions that impair the body’s ability to repair UV-damaged DNA.
Prognosis and Cure Rates
The good news about basal cell carcinoma is that it grows slowly and almost never spreads to distant parts of the body. Metastasis rates range from 0.0028 to 0.55 percent, making it one of the least dangerous cancers when caught and treated.
Five-year cure rates reflect that low risk. Standard surgical removal, along with techniques like scraping and freezing, produces cure rates of 95 percent or better. A specialized technique called Mohs surgery, where the surgeon removes tissue layer by layer and examines each one under a microscope, achieves a 99 percent cure rate for first-time tumors and up to 95 percent for cancers that have come back after previous treatment. Radiation therapy, used when surgery isn’t practical, cures about 90 percent of cases.
The real concern with BCC isn’t mortality. It’s local tissue destruction. Left untreated, a basal cell carcinoma will keep growing into surrounding tissue, potentially damaging cartilage, bone, or important structures near the eyes, nose, or ears. The morphoeic subtype is especially problematic because its invisible margins make it easy to undertreat. Having one BCC also increases your likelihood of developing another one in the future, so ongoing skin checks become important after a first diagnosis.
How BCC Compares to Squamous Cell and Melanoma
Squamous cell carcinoma, the second most common skin cancer, tends to appear on areas of chronic sun damage like the scalp, ears, backs of hands, and lower lip. It carries a slightly higher risk of spreading than BCC, though the vast majority are still curable when caught early. It often looks like a firm, red nodule or a flat sore with a scaly crust.
Melanoma is far less common than either BCC or squamous cell carcinoma but is responsible for the majority of skin cancer deaths. It develops from pigment-producing cells rather than the structural cells of the epidermis, and it can spread to lymph nodes and organs relatively quickly. Melanoma typically appears as a new or changing mole with irregular borders, uneven color, or a diameter larger than a pencil eraser.
All three types share UV exposure as a major risk factor, and all three are more treatable when found early. The key difference is urgency: a basal cell carcinoma that sits for a few months before treatment rarely changes the outcome, while a melanoma that goes unnoticed for the same period can become life-threatening.